NICE revise Alzheimer's ruling.(UK HEALTH)(National Institute for Clinical Excellence)
Publication Date: 01-MAR-06
Publication Title: European Pharmaceutical Executive
Format: Online
Author: Houlton, Sarah

Read this article now
Try Goliath Business News - FREE!
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description

The UK government has backed down on its plans to stop drugs to treat Alzheimer's disease being available on the National Health Service (NHS). Last March, the National Institute for Clinical Excellence (NICE) published a draft recommendation claiming that four drugs--Aricept (donepezil) from Eisai, Lundbeck's Ebixa (memantine), Exelon (rivastigmine) from...



More articles from European Pharmaceutical Executive
France fined for bio failure.(EUROPEAN UNION)(Brief article), March 01, 2006
Almac founder knighted.(PEOPLE)(Brief article), March 01, 2006
Sniffing out cancer.(NEW RESEARCH)(Brief article), March 01, 2006
Schizophrenia ad campaign honoured.(MEDIA)(GSW Worldwide/Junction 11)(..., March 01, 2006
HIV structure revealed.(AIDS)(Brief article), March 01, 2006

Looking for additional articles?
Click here to search our database of over 3 million articles.